It is a research combination studied for synergistic tissue repair and regeneration pathways
NA-931 peptide , The product name Bioglutide is the world's first oral quadruple receptor agonist, which demonstrates breakthrough potential in the treatment of metabolic diseases by simultaneously activating the glucagon receptor (GCGR), glucagon like peptide-1 receptor (GLP-1R), glucose dependent insulinotropic polypeptide receptor (GIPR), and insulin-like growth factor-1 receptor (IGF-1R)
With Nano-Glutathione, Niacinamide, and Vitamin C, they help visibly reduce dark spots, melasma, dark circles, and uneven skin tone
EU RP: Fragmentary Service SARL, 10 rue de la Paix, 75002 Paris, France